skip to content

Department of Chemical Engineering and Biotechnology

Released today by BioBeat, the seventh annual Movers and Shakers in BioBusiness report highlights 30 examples of resourceful leaders in the UK bioscience sector. For the first time, this year’s Movers and Shakers also features nearly 200 alumni from previous reports, including our Professor of Neurotechnology, Sabine Bahn.

The UK life sciences sector has risen to the challenges posed by COVID-19 with exceptional innovation and collaboration across industry, clinicians, the NHS, academia and government. Members of the BioBeat community are at the forefront of global scientific research and clinical trials, significantly shaping the trajectory of the pandemic.

Many of the leaders featured in the report have been instrumental in the response to the COVID-19 pandemic, while others are pioneering healthcare innovations that will bring benefits to patients across a wide range of conditions.

Professor Bahn leads the Cambridge Centre for Neuropsychiatric Research and her main research focus is to understand the molecular basis of neuropsychiatric and neurodevelopmental disorders, with a focus on the major psychotic disorders schizophrenia and bipolar disorder. She is also co-founder of Psyomics, a UK-based healthtech and University of Cambridge spin-out, which recently closed a £1.5 million funding round from existing and new investors to bring its mental health assessment and diagnosis platform, Censeo, to market in the UK. 

Bahn was highlighted in several previous Movers and Shakers reports, and as a 'BioBeat alumna', is recognised as an inspirational leader in UK bioscience.

Taking the theme ‘Connecting for Strength’, the 2020 report showcases women at the forefront of the UK’s flourishing life sciences sector including:

  • Pioneering scientists developing revolutionary healthcare products
  • Financial experts shaping the sector through diverse investments
  • Motivating and inclusive collaborators who get the job done
  • Innovators whose inventions are making an impact on patients’ lives
  • Infrastructure specialists supporting innovation at scale, from concept to execution

Introducing the report, Kate Bingham, Chair of the UK Vaccine Task Force, trustee of the Francis Crick Institute and Managing Partner at SV Health Investors, says: “The women profiled within this report are outstanding leaders who are changing the face and future of healthcare. Each has contributed immensely to the UK’s world-class science, retaining talent, driving economic growth and improving patient care through the COVID-19 pandemic and beyond. Their successes will inspire our next generation of scientists and encourage the growth of a more diverse talent pool.”

BioBeat founder Miranda Weston-Smith adds: “It is the strength in our human connections that enables entrepreneurs and researchers to bring ideas to life. The COVID-19 pandemic has brought out the very best of British science, highlighting the resilience of the sector and our capacity for collaboration and innovation. Congratulations to all the leaders profiled in this year’s report, and heartfelt thanks to the nominators and expert reviewers who provide their time and insights to make this such a valuable resource.”

The Movers and Shakers in BioBusiness report is released in advance of the BioBeat20 Summit: Accelerating data-driven health on Tuesday 17th November 2020, in partnership with the Francis Crick Institute.

Delivered as an online event this year, the summit will bring together leading experts to discuss the tipping points for data-driven health adoption and investment.

The full Movers & Shakers in BioBusiness 2020 report is available to download from 10.00 GMT on 10th November 2020 at mws-consulting.co.uk/news-publications/

Free registration is now open for the BioBeat20 summit: Accelerating data-driven health at crick.ac.uk/whats-on/biobeat20

About BioBeat

BioBeat connects entrepreneurs with leaders in bioscience, by working to respond to challenges and open opportunities through the inspirational experience of women leaders. Miranda Weston-Smith founded BioBeat to bring fresh energy and insights for a healthier world.

BioBeat has produced the Movers & Shakers in BioBusiness report every year since 2014, identifying outstanding female leadership talent in UK bioscience. The annual BioBeat summit brings together pioneers in biotech to nurture innovation and forge new partnerships.

Find out more at mws-consulting.co.uk/biobeat/  

Latest news

Multi-million pound research centre in AI to spark digital revolution in chemical industry

12 November 2020

The new Innovation Centre in Digital Molecular Technologies aims to accelerate access to pharmaceuticals, agrochemicals, functional molecules and molecular materials through machine learning and robotics-based synthesis.

Professor Sabine Bahn highlighted in Movers and Shakers in BioBusiness report

10 November 2020

Released today by BioBeat, the seventh annual Movers and Shakers in BioBusiness report highlights 30 examples of resourceful leaders in the UK bioscience sector. For the first time, this year’s Movers and Shakers also features nearly 200 alumni from previous reports, including our Professor of Neurotechnology, Sabine Bahn.

Psyomics secures £1.5m funding to transform mental health diagnosis in the UK

28 October 2020

Psyomics Ltd, a UK-based healthtech and Unviersity of Cambridge spin-out, has closed a £1.5 million funding round from existing and new investors to bring its mental health assessment and diagnosis platform, Censeo, to market in the UK.